Patented Drugs Cheaper In India, But Less Affordable, Study Says
This article was originally published in PharmAsia News
Executive Summary
Patented drugs sold in India cost nearly half as much as in Brazil, China, Indonesia, Mexico and South Africa, but are less affordable to Indians because their government provides little or no help, according to a commissioned study.